定量CT预测特发性肺纤维化结局
本研究基于澳大利亚IPF注册队列,对393例患者的基线CT采用数据驱动纹理分析(DTA)量化肺纤维化范围。线性混合模型显示基线DTA评分与FVC及DLCO年下降率显著相关;多变量Cox分析中纤维化范围越大,无移植生存(HR 1.20,p<0.0001)和无进展生存(HR 1.14,p<0.0001)越差。
要点
- 基线CT的DTA纤维化评分与FVC和DLCO年下降率独立相关。
- 纤维化范围越大,无移植生存和无进展生存越差。
- DTA量化纤维化程度可辅助IPF预后评估。
核心结论
- 基线CT经DTA量化的纤维化范围与IPF患者结局独立于肺功能相关。
研究设计与样本
- 回顾性分析澳大利亚IPF注册队列2007—2016年有可用CT的参与者,共分析393例CT,其中221例有CT后90天内肺功能检查。
主要发现
- 线性混合效应模型显示基线DTA评分与FVC及DLCO年下降率显著相关。
- 多变量Cox模型中纤维化范围越大与无移植生存越差相关(HR 1.20,p<0.0001)。
- 多变量Cox模型中纤维化范围越大与无进展生存越差相关(HR 1.14,p<0.0001)。
临床怎么用
- 对IPF患者可考虑用CT的DTA量化纤维化范围辅助预后分层。
- DTA评分可与肺功能指标结合用于随访评估。
局限性
- 回顾性分析,仅221例有CT后90天内肺功能检查。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVE: Prediction of disease course in patients with progressive pulmonary fibrosis remains challenging. The purpose of this study was to assess the prognostic value of lung fibrosis extent quantified at computed tomography (CT) using data-driven texture analysis (DTA) in a large cohort of well-characterized patients with idiopathic pulmonary fibrosis (IPF) enrolled in a national registry. METHODS: This retrospective analysis included participants in the Australian IPF Registry with available CT between 2007 and 2016. CT scans were analysed using the DTA method to quantify the extent of lung fibrosis. Demographics, longitudinal pulmonary function and quantitative CT metrics were compared using descriptive statistics. Linear mixed models, and Cox analyses adjusted for age, gender, BMI, smoking history and treatment with anti-fibrotics were performed to assess the relationships between baseline DTA, pulmonary function metrics and outcomes. RESULTS: CT scans of 393 participants were analysed, 221 of which had available pulmonary function testing obtained within 90 days of CT. Linear mixed-effect modelling showed that baseline DTA score was significantly associated with annual rate of decline in forced vital capacity and diffusing capacity of carbon monoxide. In multivariable Cox proportional hazard models, greater extent of lung fibrosis was associated with poorer transplant-free survival (hazard ratio [HR] 1.20, p < 0.0001) and progression-free survival (HR 1.14, p < 0.0001). CONCLUSION: In a multi-centre observational registry of patients with IPF, the extent of fibrotic abnormality on baseline CT quantified using DTA is associated with outcomes independent of pulmonary function.
引用
- Humphries SM, Mackintosh JA, Jo HE, et al. Quantitative computed tomography predicts outcomes in idiopathic pulmonary fibrosis. Respirology. 2022. PMID: 35875881. doi:10.1111/resp.14333
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。